The US Oncology Network to Standardize on Elekta’s MOSAIQ Oncology Information System
The US Oncology Network (The Woodlands, Texas) – among the largest networks of community-based oncology physicians in the United States – has selected Elekta’s MOSAIQ® Oncology Information System (OIS) as the standard radiation oncology OIS across The Network. In the agreement, The Network committed to purchase five Elekta Infinity™ linear accelerators.The order was booked during Elekta’s third quarter 2011/12.
The recent agreement continues The US Oncology Network’s long-standing relationship with Elekta, as many Network practices are already MOSAIQ users.
“We have found the MOSAIQ OIS software to be very workflow friendly – it increases productivity within our radiation therapy departments,” says Charles Smith PhD, The US Oncology Network Vice President of Cancer Center Services. “Standardizing on the same MOSAIQ version across the entire enterprise will enable us to implement and share best workflow practices and help us to deliver high quality radiation therapy in a cost effective way.”
Dr. Vivek Kavadi, Radiation Oncology Medical Director for The US Oncology Network, says: “This MOSAIQ investment will enable radiation oncologists across The US Oncology Network to better share clinical best practices and support our integrated care platform.”
MOSAIQ is a comprehensive vendor neutral OIS that centralizes radiation oncology and medical oncology patient data into a single user interface, accessible by multidisciplinary teams across multiple locations. MOSAIQ provides hospitals and oncology staff access to the underlying clinical and administrative data, improving both clinical care and operational effectiveness.
“We’re gratified by the confidence The US Oncology Network has demonstrated in selecting Elekta information management and treatment solutions,” says James Hoey, Executive Vice President, Elekta North America. “We look forward to building on our long and close relationship with The Network.”
For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: [email protected]
Time zone: CET: Central European Time
Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: [email protected]
Time zone: ET: Eastern Time
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451, email: [email protected]
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07.30 CET on May 24, 2012.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
About The US Oncology Network
The US Oncology Network is one of the United States’ largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Like-minded physicians are united through The Network around a common vision of expanding patient access to high-quality, integrated cancer care in communities throughout the nation. Leveraging healthcare information technology, shared best practices, refined evidence-based medicine guidelines, and quality measurements, physicians affiliated with The US Oncology Network are committed to advancing the quality, safety, and science of cancer care to improve patient outcomes.
The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system to advance the science, technology and quality of care. For more information, visit www.usoncology.com.